Anacura proudly announces the launch of Discovery Studio, a new independent biotech & medtech accelerator dedicated to supporting innovative projects addressing unmet medical needs.

Built on decades of experience in quality-driven biology services, Discovery Studio combines industrial robustness with academic creativity to accelerate early-stage research and therapeutic innovation. The new business unit offers a complete project biology support environment, integrating state-of-the-art computational drylab capabilities, advanced cellular in vitro wetlab infrastructure, extensive analytical equipment, and a strong network of expert scientists.

Discovery Studio focuses on cellular biology-centric and evidence-based value creation. By combining expertise in omics, bioinformatics, and in vitro assay development, the team supports biotech and medtech innovators in efficiently advancing promising medical approaches towards meaningful value inflection points and therapeutic relevance.

The accelerator is designed to help partners optimize research efficiency and focus investment where it creates the greatest impact. Through tailored scientific support structures and high-quality project execution, Discovery Studio aims to bridge the gap between early-stage innovation and patient-oriented applications.

With this launch, Anacura further strengthens its commitment to accelerating scientific innovation and supporting the development of next-generation healthcare solutions.